Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Seres Therapeutics, Inc. | 7,838 | reported | 18 May 2026 | tx 27+84,187−6,762 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 238 | — | 10b5-1 |
| 18 May 2026 | SALE | Seres Therapeutics, Inc. | 77 | 7.53 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 141 | 0.00 USD | 10b5-1deriv |
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 97 | 0.00 USD | 10b5-1deriv |
| 04 Mar 2026 | GRANT_AWARD | Seres Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 239 | — | |
| 15 Feb 2026 | SALE | Seres Therapeutics, Inc. | 89 | 8.47 USD | |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 141 | 0.00 USD | deriv |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 98 | 0.00 USD | deriv |
| 15 Nov 2025 | SALE | Seres Therapeutics, Inc. | 1,257 | 17.30 USD | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 98 | — | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 3,998 | — | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 140 | — | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 3,998 | 0.00 USD | deriv |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 140 | 0.00 USD | deriv |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 98 | 0.00 USD | deriv |
| 26 Sept 2025 | GRANT_AWARD | Seres Therapeutics, Inc. | 3,998 | 0.00 USD | deriv |
| 18 Aug 2025 | SALE | Seres Therapeutics, Inc. | 73 | 16.65 USD | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 97 | — | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 141 | — | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 97 | 0.00 USD | deriv |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 141 | 0.00 USD | deriv |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 140 | — | |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 98 | — | |
| 16 May 2025 | SALE | Seres Therapeutics, Inc. | 77 | 7.28 USD |